Paul J. Carter

Paul Carter is a pioneer in antibody engineering who has made foundational contributions to bispecific antibody design and development. His work at Genentech has led to multiple bispecific antibody formats that enable T cell engagement and other novel mechanisms for cancer therapy. Carter's innovations in antibody architecture have enabled clinical development of several bispecific therapeutics.

Paul Carter是抗体工程的先驱，在双特异性抗体设计和开发方面做出了基础性贡献。他在基因泰克的工作产生了多种双特异性抗体形式，能够实现T细胞结合和其他新型癌症治疗机制。Carter在抗体架构方面的创新使多种双特异性治疗药物的临床开发成为可能。